BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9687844)

  • 41. Should Europe have a universal hepatitis B vaccination programme?
    Van Damme P; Leuridan E; Hendrickx G; Vorsters A; Theeten H; Leino T; Salminen M; Kuusi M
    BMJ; 2013 Jul; 347():f4057. PubMed ID: 23843546
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hepatitis B vaccination is still current].
    Kremp O
    Soins Pediatr Pueric; 1999; (187):31-2. PubMed ID: 10615148
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anti-hepatitis B and anti-Haemophilus influenzae type b vaccines].
    Dias PG
    Acta Med Port; 1997; 10(2-3):129-38. PubMed ID: 9235843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis-B vaccination.
    Phadke A; Kale A
    J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
    [No Abstract]   [Full Text] [Related]  

  • 47. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. School-based adolescent hepatitis B vaccination.
    Cassidy WM
    J La State Med Soc; 1999 Dec; 151(12):622-6. PubMed ID: 10643204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined prevention of hepatitis A and B].
    Fortschr Med; 1997 May; 115(13):18. PubMed ID: 9324474
    [No Abstract]   [Full Text] [Related]  

  • 50. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 51. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
    Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
    Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
    [No Abstract]   [Full Text] [Related]  

  • 52. Timing of zero dose of OPV, first dose of hepatitis B and BCG vaccines.
    Kuruvilla TA; Bridgitte A
    Indian Pediatr; 2009 Nov; 46(11):1013-5. PubMed ID: 19671951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protecting the innocent.
    Ortolon K
    Tex Med; 2003 Sep; 99(9):43-6. PubMed ID: 14650803
    [No Abstract]   [Full Text] [Related]  

  • 54. Cost-effectiveness of hepatitis B virus immunization.
    Everett WD
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598610
    [No Abstract]   [Full Text] [Related]  

  • 55. Cost-effectiveness of hepatitis B virus immunization.
    Watters JK; Kral AH
    JAMA; 1996 Mar; 275(12):907-8. PubMed ID: 8598609
    [No Abstract]   [Full Text] [Related]  

  • 56. Cost-effectiveness of hepatitis B virus immunization.
    Edmunds WJ; Medley GF; Nokes DJ
    JAMA; 1996 Mar; 275(12):907; author reply 909. PubMed ID: 8598608
    [No Abstract]   [Full Text] [Related]  

  • 57. Cost-effectiveness of hepatitis B serology testing before hepatitis B vaccination in the Akha tribal children in northeastern Thailand.
    Custodio H; Mirza A; Salahuddin A; Ferguson K; Rathore M
    Pediatr Infect Dis J; 2011 Aug; 30(8):725. PubMed ID: 21750450
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children.
    Mphahlele MJ; Burnett RJ; Kyaw T; Schoeman HS; Aspinall S
    S Afr Med J; 2004 Apr; 94(4):280-1. PubMed ID: 15150941
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on immunization strategies for hepatitis B in different endemic areas of China].
    Wang L; Li H; Wang S; Gong J; Zeng X; Li R; Nong Y; Huang Y; Chen X; Huang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):104-6. PubMed ID: 11864465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B immunization.
    Simkiss D
    J Trop Pediatr; 2002 Oct; 48(5):256-7. PubMed ID: 12405165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.